Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C22orf39 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PRH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DALRD3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LY6L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | GOLGA8J | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FAM120B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GPR88 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | PLCH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPF2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DPAGT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |